Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

@article{Barnes2011EvidencebasedGF,
  title={Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology},
  author={T. Barnes},
  journal={Journal of Psychopharmacology},
  year={2011},
  volume={25},
  pages={567 - 620}
}
  • T. Barnes
  • Published 2011
  • Medicine
  • Journal of Psychopharmacology
  • These guidelines from the British Association for Psychopharmacology address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving experts in schizophrenia and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from the participants and interested parties, and cover the pharmacological management and treatment of schizophrenia across the various… CONTINUE READING

    Topics from this paper.

    Clozapine: a review of clinical practice guidelines and prescribing trends
    • 108
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 1,094 REFERENCES
    Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    • 4,693
    • PDF
    The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.
    • 526
    • PDF
    The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.
    • 792
    • PDF
    The Brief Psychiatric Rating Scale
    • 9,683
    • PDF